ArticleVaccine2024

Development of a Shigella conjugate vaccine targeting Shigella flexneri 6 that is immunogenic and provides protection against virulent challenge.

Meagan Kelly et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.